http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
윗등뼈 도수치료가 전방머리자세를 지닌 만성 여성 목통증 환자에게 미치는 영향
Effect of Upper Thoracic Manipulation on women Chronic Neck pain patients with Forward head posture 대한치료과학회 2014 대한치료과학회지 Vol.6 No.2
Objective: This study seeks to establish the benefits of Upper Thoracic Manipulation on chronic neck pain patients with forward head posture by examining positive changes in their degree of neck pain, physical functioning, posture, pulmonary function and chest mobility. Method: 30 women with chronic neck pain patients with forward head posture who were receiving physical therapy in H hospital were divided into a Upper Thoracjc Manipulation Group(TMG) and a Upper Thoracic self Exercise Group(TEG). One group was treated by upper thoracjc manipulation and the other group by upper thoracic self exercise 3 times a week for 8 weeks. Evaluation were made on Visual Analogue Scale(VAS), Neck Dysfunction Index(NDI), Cranio Vertebral Angle(CVA), Pulmonary Function(PF) and Chest Expansion(CE). Repeated measure ANOVA was used to compare the evaluations of results before the experiment, results after 4 weeks, and results after 8 weeks. ANCOVA was used to compare between the groups. Results: In VAS, NDI, CVA, PF and CE both TMG and TEG showed weekly differences(p<.05). TMG showed more reduction in VAS, NDI more increase in CVA, PF and CE. Conclusion: In this study it showed that TMG is more effective than TEG on chronic neck pain patients with forward head posture in VAS, NDI, CVA, PF and CE.
Sung Eun Kim,정혜경,Seung Joo Kang,이용찬,Hyo-Joon Yang,Seon-Young Park,Cheol Min Shin,임현철,김지현,Su Youn Nam,Woon Geon Shin,Jae Myung Park,Il Ju Choi,김재규,Miyoung Choi,Korean College of Helicobacter and Upper 대한상부위장관ㆍ헬리코박터학회 2021 Korean Journal of Helicobacter Upper Gastrointesti Vol.21 No.1
Background/Aims: The eradication rate of the first-line standard triple therapy (STT) for Helicobacter pylori (H. pylori) infection has decreased since 2000; therefore, other first-line therapies are required. This study was aimed at investigating the efficacy of bismuth- containing quadruple therapy (PBMT) for first-line H. pylori eradication compared to STT, sequential therapy (SQT), and concomitant therapy (CT). Materials and Methods: The Ovid-MEDLINE, Koreamed, EMBASE, KMBASE, and Cochrane Library databases were searched from January 2008 to July 2018. All identified randomized controlled trials (RCTs) comparing PBMT and non-PBMT for first-line H. pylori eradication therapy were included in the final analysis. Results: A total of 3,653 patients from seven RCTs were enrolled. The pooled eradication rates of PBMT by intention-to-treat (ITT) and per-protocol (PP) analyses were 82.1% (95% CI, 68.2~90.8%) and 88.8% (95% CI, 77.1~94.9%), respectively. However, no statistically significant difference was observed in eradication rates of the 10- or 14-day PBMT as compared to 14-day STT, 10-day SQT, and 10-day CT in ITT and PP analyses. PBMT was significantly higher in adverse events than in the other eradication regimens (RR, 1.64; 95% CI, 1.11~2.44). Considerable heterogeneity in adverse events was observed among studies (χ2=88.7; P<0.001, I2=93%). Conclusions: PBMT can be the first-line treatment for H. pylori eradication in Korea when other first-line options, including STT, SQT, or CT, are unavailable due to their high adverse event rates.